• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

Methyl 6-bromo-2-fluoro-3-methylbenzoate (CAS No. 1437780-03-4): A Versatile Intermediate for Pharmaceutical and Agrochemical Applications

Methyl 6-bromo-2-fluoro-3-methylbenzoate (CAS No. 1437780-03-4) is a highly valuable aromatic ester compound that has gained significant attention in recent years due to its versatile applications in pharmaceutical synthesis and agrochemical development. This fluorinated benzoate derivative serves as a crucial building block for the preparation of various biologically active molecules, making it an essential component in modern organic chemistry research and industrial applications.

The molecular structure of Methyl 6-bromo-2-fluoro-3-methylbenzoate features three strategically positioned substituents: a bromine atom at the 6-position, a fluorine atom at the 2-position, and a methyl group at the 3-position of the benzene ring. This unique arrangement of functional groups makes it particularly valuable for Suzuki coupling reactions and other transition metal-catalyzed cross-coupling processes, which are fundamental to contemporary drug discovery programs.

Recent trends in pharmaceutical research have shown increased demand for fluorinated compounds like Methyl 6-bromo-2-fluoro-3-methylbenzoate, as the introduction of fluorine atoms into drug candidates often improves their metabolic stability, bioavailability, and binding affinity to target proteins. This aligns perfectly with current industry focus on developing more effective and longer-lasting medications, particularly in areas such as central nervous system (CNS) drugs and anticancer agents.

In agrochemical applications, Methyl 6-bromo-2-fluoro-3-methylbenzoate serves as a precursor for the synthesis of novel crop protection agents. The presence of both bromine and fluorine atoms in its structure allows for the development of compounds with enhanced pesticidal activity and improved environmental profiles. This is particularly relevant given the growing global demand for sustainable agricultural solutions that can address challenges posed by pesticide resistance and stricter environmental regulations.

The synthesis of Methyl 6-bromo-2-fluoro-3-methylbenzoate typically involves multi-step processes starting from commercially available methyl 2-fluoro-3-methylbenzoate. The bromination step is carefully controlled to achieve selective substitution at the 6-position, which is crucial for maintaining the compound's reactivity profile. Recent advances in green chemistry have led to improved synthetic routes that reduce waste generation and energy consumption during production.

Quality control for Methyl 6-bromo-2-fluoro-3-methylbenzoate involves rigorous analytical techniques including HPLC analysis, GC-MS, and NMR spectroscopy to ensure high purity levels typically exceeding 98%. The compound's stability under various storage conditions has been extensively studied, with recommendations for storage in cool, dry environments away from strong oxidizing agents to maintain optimal shelf life.

Market analysis indicates steady growth in demand for Methyl 6-bromo-2-fluoro-3-methylbenzoate, particularly from pharmaceutical companies engaged in small molecule drug development. The compound's versatility as a synthetic intermediate has made it increasingly popular among contract research organizations (CROs) and academic research institutions working on medicinal chemistry projects.

Recent publications have highlighted innovative applications of Methyl 6-bromo-2-fluoro-3-methylbenzoate in the development of kinase inhibitors and G-protein coupled receptor (GPCR) modulators. These findings have sparked additional interest from the research community, leading to increased patent activity surrounding derivatives of this compound.

From a regulatory perspective, Methyl 6-bromo-2-fluoro-3-methylbenzoate is classified as a standard chemical substance with no special handling requirements beyond basic laboratory safety protocols. This favorable regulatory status contributes to its widespread availability and use across multiple research and industrial settings.

The future outlook for Methyl 6-bromo-2-fluoro-3-methylbenzoate appears promising, with anticipated growth driven by expanding applications in both pharmaceutical and agrochemical sectors. Ongoing research into novel synthetic methodologies and the continuous discovery of new biological activities for its derivatives ensure that this compound will remain an important tool for chemical innovation in the coming years.

For researchers considering working with Methyl 6-bromo-2-fluoro-3-methylbenzoate, it's important to note that proper characterization of reaction products and thorough purification processes are essential to achieve optimal results. The compound's reactivity profile makes it particularly valuable for constructing complex molecular architectures found in many modern therapeutics and agricultural chemicals.

In conclusion, Methyl 6-bromo-2-fluoro-3-methylbenzoate (CAS No. 1437780-03-4) represents a strategically important chemical building block that continues to enable advancements in multiple scientific disciplines. Its unique combination of functional groups and proven utility in diverse synthetic applications ensure its ongoing relevance in chemical research and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)